Research Article

 

Immunomodulatory and Anti-angiogenic Properties of Linum usitatissium (flaxseed) Seeds Ethanolic Extract in Atherogenic Diet Treated Rats

 

Ibrahim A. Ibrahim1, Abeir A. Shalaby1, Hoda ML. Abdallah2, Nermin F. El Zohairy2, Hoda I. Bahr1*

1Department of Biochemistry, Faculty of Vet. Medicine, Suez Canal University Ismailia 41522, Egypt; 2Department of Biochemistry, Animal Health Research Institute, Zagazig, Egypt.

 

Abstract | We determined the cardioprotective impact of ethanolic flaxseed seeds extract through an assessment of its immunomodulatory and antiangiogenic characteristics in rats fed with an atherogenic diet. Group 1 fed on the standard diet. Groups 2 and 3 fed on an atherogenic diet (AD) for 12 weeks. Groups 3 and 4 daily supplemented with ethanolic extract of flaxseed seeds (EEFS) 400mg/kg b.w starting from 7th week till the end of 12th week. AD-fed rats had increased serum lipids, CRI-I, CRI-II, cardiac enzymes, and pro-inflammatory markers. Compared to the AD-fed group, EEFS supplementation influenced hypo-lipidemic, anti-inflammatory, anti-angiogenic, and anti-atherogenic characteristics after AD- feeding. EEFS displayed antioxidant capacity in vitro and in vivo. Chromatographic analysis of EEFS demonstrated the presence of phenolic, flavonoid compounds, and vitamin C. The data concludes a safe application of EEFS in atherogenesis-induced cardiac disease management.

 

Keywords | Hyperlipidemia, Cardiac markers, Immunity, Linum usitatissimum

 

Received | June 10, 2020; Accepted | June 25, 2020; Published | July 10, 2020

*Correspondence | Hoda Ibrahim Bahr; Department of Biochemistry, Faculty of Vet. Medicine, Suez Canal University Ismailia 41522, Egypt; Email: bio_canal@yahoo.com

Citation | Ibrahim IA, Shalaby AA, Abdallah HML, El-Zohairy NF, Bahr HI (2020). Immunomodulatory and anti-angiogenic properties of Linum usitatissium (flaxseed) seeds ethanolic extract in atherogenic diet treated rats. Adv. Anim. Vet. Sci. 8(s1): 18-25.

DOI | http://dx.doi.org/10.17582/journal.aavs/2020/8.s1.18.25

ISSN (Online) | 2307-8316; ISSN (Print) | 2309-3331

Copyright © 2020 Lukkananukool et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

 

Introduction

 

Hyperlipidemia occurs by a rise in total cholesterol (TC), triacylglycerol (TAG), low-density lipoprotein cholesterol (LDL-C) and reduced high-density lipoprotein cholesterol (HDL-C) (Rahaman et al., 2013). High cholesterol diet results in fatty liver, atherosclerosis, and heart failure (Machado and Diehl., 2016; Wójcik-Cichy et al., 2018). Oxidative stress can modulate immunity via controlling expression of cytokines (IL6) that regulate weight and metabolism (Walaa et al., 2019; Fernández-Gayol et al., 2019). Atherosclerotic plaque is formed when there is an engulfment of LDL-C by macrophages Producing foam cells and proinflammatory cytokines (Hopkins, 2013). Sub-endothelial oxidative stress contributes to the oxidization of LDL-C formation and the development of fatty streak (Brites et al., 2017).

 

Herbs have gained a much important medical role in recent years (Karam et al., 2017). Linum usitatissimum (flaxseed or linseed) contains α-linolenic acid (α-ALA), secoisolariciresinol diglucoside (SDG) lignan, and dietary fiber (Hall et al., 2006). Flaxseed has antioxidant, anti-inflammatory, anti-atherosclerotic, and cardio-protective properties (Zanwar et al., 2011; Naik et al., 2018). Daily supplementation of ethanolic extract of flaxseed (400mg/kg for three weeks exhibited hypoglycemic and antioxidant properties in diabetic rats (Ghule et al., 2012). With reduced LDL-C and increased HDL-C level, administration of ground flaxseed (15g/100 gm diet for 20-week) displayed a cardioprotective effect in AD-fed diabetic hamsters (Haliga et al., 2015). Flaxseed oil downregulated hepatic expression of a gene involved in lipid metabolism, TNF, IL-6, and ICAM in apo-E deficient mice (Han et al., 2015). Since there are limited studies on immunomodulatory and cardio-protective aspects of flaxseed seeds ethanolic extractThis work was conducted to determine the anti-inflammatory, anti-angiogenic, and anti-atherogenic impact of ethanolic flaxseed seeds extract in atherogenic dietfed rats. These characteristics were assessed through cardiac, and inflammatory markers, and expression of HMGCR and VEGF. Phytochemical identification of flaxseed seeds ethanolic extract was also performed to detect total phenolic, flavonoids, vitamin C contents.

 

Materials and Methods

 

Animals

Forty Wistar male rats (120-130gm) were obtained from the National Research Center Laboratory Animal House, Dokki, Giza, Egypt. Animals were kept in the animal house at the Faculty of Veterinary Medicine, Suez Canal University. The study was carried out in accordance with the «Guide for the Care and Use of Laboratory Animals». Atherogenic diet (AD) comprised of basal diet (355 gm/kg), cholesterol (10gm/kg), lard (310gm/kg), corn oil (10gm/kg), DL-Methionine(3gm/kg), casein (250 gm/kg), vitamin and mineral mix 60gm/kg), Yeast powder (1gm/kg), and sodium chloride mix (1 gm/kg) (Srinivasan et al., 2005).

 

Flaxseed seeds Ethanolic extract preparation

Flaxseed seeds were obtained from the Department of Horticulture, Agricultural Research Center, Dokki, Giza, Egypt, and confirmed at a facility in the Pharmacognosy Department, Faculty of Pharmacy, Cairo University, Egypt. Flaxseed seeds (500 g) were washed with distilled water, dried in hot air oven (40–60 oC), grounded, soaked twice in 96% ethanol for 24 hr, filtered, dried the filtrate, and stored at 4°C until further use (Samson et al., 2012).

 

Experimental protocol

Rats were divided into four groups, (n=10 each). Group I (Control) fed on basal pelleted diet and water. Starting from 7th week of the experiment, rats were supplemented with 1ml distilled water per-os daily till the end of the experiment (12th week). Group II (AD) fed the atherogenic diet (AD) for three months. Starting from 7th week of the experiment, rats were supplemented with 1ml distilled water per-os daily till the end of the experiment. Group III(AD+EEFS) fed AD for three months. Starting from the 7th week, rats were supplemented with ethanolic extract of flaxseed seeds (EEFS) 400mg/kg/day (Ghule et al., 2012). Group IV (EEFS) fed on a standard rat pelleted diet for three months. Starting from 7th week, rats were supplemented with EEFS 400mg/kg/day till the end of the experiment.

 

Collection of blood, liver and heart samples

At the end of the experiment, rats were fasted overnight and euthanized. Blood samples were collected and centrifuged for serum separation. Heart and liver samples were dissected. Liver tissues were kept at -80°C for as an assessment of the rate of expression of HMGCR, and VEGF. Heart tissue was used for histological analysis.

Analysis of serum lipid profile, cardiac enzyme activity, and inflammatory markers

Commercially available kits were used to determine TC (Cat. No.1105, Vitro Science, Egypt), TAG (Cat. No. 702040050, Vitro Science, Egypt), HDL-C (Cat. No. 282000005, Vitro Science, Egypt). Lactate dehydrogenase (LDH) LDH ELISA Kit, Cat. No. MBS043166, MyBioSource, USA, creatinine kinase- MB (CK-MB) CK-MB Isoenzyme ELISA Kit, Cat. No: MBS008782, MyBioSource, USA, aspartate aminotransferase (AST), Cat. No. TR70121, Thermo Fisher Scientific, USA, serum high-sensitivity C-Reactive Protein (hs-CRP), hs-CRP ELISA kit, Cat. No: MBS2500438 MyBioSource, USA, Interleukin-6 (IL-6) IL-6 ELISA kit, Cat. No: MBS355410 MyBioSource, USA, and Interleukin-10 (IL-10) IL-10 ELISA kit, Cat No. MBS175998, MyBioSource, USA as per manufacturer’s instructions. Previously published protocols and procedures were used to determine the concentration of LDL- C, (Davidson and Rosenson, 2009), VLDL- C (Zhao et al., 2017), and Castelli Risk Index (CRI-I and CRI-II) cardiovascular risk (Olamoyegun et al., 2016).

 

Molecular investigations

The extraction of total RNAs of the liver was done (RNeasy Mini Kit, Qiagen) following manufacturer guidelines. Transformation of RNA to cDNA was carried out (RevertAid Reverse Transcriptase (cDNA synthesis kit, ThermoFisher, Catalog number: EP0441). QuantiTect SYBR green PCR kit (3 x 1.7 ml 2x QuantiTect SYBR Green PCR Master Mix, 2 x 2 ml RNase-Free Water, Cat. No./ID: 204143 ) was applied to quantify 3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMGCR) (Morral et al., 2007), and vascular endothelial growth factor (VEGF) expression (Peng et al., 2014). Previously published primers and probes were synthesized (Metabion, Germany) (Table 1). Thermal conditions included 94°C for 15 min, followed by 40 cycles of each of 94°C for 15s and 60°C for the 30s. Endogenous gene (β-actin) was used for normalization, and expression quantification was determined (Bahr et al., 2019).

Quantification of phenolic, flavonoid compounds and antioxidant activity

Total phenolics levels in EEFS were evaluated using the Folin-Ciocalteau assay and described as gallic acid equivalents (GAE/g) extract (Dandge et al., 2011). Total flavonoid level was detected and described as quercetin equivalents (mg QE /g)) according to the previously described method (Kumar and Roy, 2018). DPPH (2,2-diphenyl-2-picryl-hydrazyl free radical) assay was used to determine the antioxidant activity in EEFS (Norshazila et al., 2010).

 

Chromatographic identification of EEFS total phenolic, flavonoids and vitamin C content

For the detection of phenolic compounds, standards such as gallic, p-coumaric, caffeic, syringic, cinnamic, chlorogenic, and ferulic acid were used.Referring to flavonoids, standard such as kaempferol, catechins, quercetin, rutin, hesperetin, rosmarinic acid, quercitrin, and apigenin were applied. Vitamin C standard was used for its measurement. The contents of the above said components were determined through HPLC (Agilent Technologies, USA) following the previously published protocol (Croci et al., 2009).

 

Statistical analysis

The results were analyzed through (SPSS, version 20). Data were described as mean± SD. One-way Analysis made a comparison of Variance (ANOVA) followed by Duncan Multiple Range Test. The significance was considered at P<0.05.

 

Results

 

Effect of flaxseed seeds ethanolic extract on lipid profile, cardiac, inflammatory, and angiogenic markers in AD- treated groups

AD induced hyperlipidemia displayed an increased TC, TAG and LDL-C, VLDL-C values, along with an upregulation in the rate of expression HMGCR. The HDL-C concentration as decreased on the other hand. An elevated CRI-I, CRI-II, LDH, and AST activity indicated the risk of cardiovascular disease. Inflammatory and oxidative burden as indicated by higher serum pro-inflammatory IL 6, hs-CRP level, and a regressed level of the antioxidant IL-10. An over-expression of VEGF was observed than control. EEFS treatment after AD-feeding resulted in hypolipidemic, anti-inflammatory, antioxidant, antiangiogenic, and antiatherogenic effects. No significant difference was observed between EEFS and control rats indicating its safe usage (Figures 1, 2, 3 and 4).

 

Histological picture of heart and aorta

Figure 5A showed regular arranged cardiac myofibers with single, ovoid, and centrally located nuclei myocytes in the heart of the control group. Figure 5B, C exhibited normal intimal, medial,and adventitial structures of the aorta. Heart section in AD-group (Figure 5D) showed severe myocardial degenerative changes with disarrayed of cardiac myofibers. Hyaline degeneration, interstitial edema along with cardiac hypertrophy, severe congestion, and dilatation of blood vessels was also observed. Aorta section of the AD-group displayed intimal-vacuolation of the endothelial cells (Figure 5E). Atheromatous plaques (round cells and macrophages were formed from fat vacuoles under the endothelium (Figure 5F). Focal endothelial destruction of the endocardium with subendothelial deposition of fat vacuole was observed (Figure 5G, 5H). Heart section in the AD+EEFS group displayed tissue restoration with mild hyaline degeneration, interstitial edema, and congested blood vessels (Figure 5I). Aorta presented normal tunica intima, tunica media, and tunica adventitia (Figure 5J). The presence of a few degenerative and necrotic changes in the endothelial and subendothelial layers was also evident (Figure 5K).

 

Figure 1: The effect of flaxseed seeds ethanolic extract on lipid profile in AD- treated groups.

Data set as (Mean ± S.D). Means with different superscript letters within the same raw are significantly different at P<0.05. AD: atherogenic diet; EEFS: ethanol extract of flaxseed seeds.

 

Figure 2: The effect of flaxseed seeds ethanolic extract on cardiac markers in AD- treated groups.

 

Figure 3: The effect of flaxseed seeds ethanolic extract on inflammatory markers in AD- treated groups.

 

Table 1: HMGCR and VEGF rat primers sequences.

 

References

Sequences of rat specific primers (5'-3') Gene
Banni et al. (2010) TCCTCCTGAGCGCAAGTACTCT Rat ß-actin
GCTCAGTAACAGTCCGCCTAGAA
Peng et al. (2014) GGCTCTGAAACCATGAACTTTCT VEGF
GCAGTAGCTGCGCTGGTAGAC
Morral et al. (2007) CAGCACTGTCGTCATTCATTTCC HMGCR
ACATTCCACCAGAGCGTCAAGG

 

Figure 4: The effect of flaxseed seeds ethanolic extract on liver mRNA expression of HMGCR and VEGF in AD- treated groups.

Data noted as (Mean ± S.D). Means with different superscript letters within the same raw are significantly different at P<0.05. AD: high fat diet, EEFS: ethanol extract of flaxseed seeds. (A) HMGCR: 3-hydroxy-3-methylglutaryl-coenzyme A reductase (B) VEGF: vascular endothelial growth factor.

 

Quantification of phenolic, flavonoids, and antioxidant capacity of EEFS

The total phenolic content was found to be 16.15 ±0.59mg GAE /g, while the concentration of total flavonoids was 2.5±0.58mg QE mg/g, and had antioxidant activity as 132.49±0.56 (Table 2).

 

Table 2: Measurement of total phenolic, flavonoids, vitamin C content and antioxidant capacity of EEFS.

 

Antioxidant capacity (μg/ml)

Total flavonoids

(mg QE /g)

Total phenolic

(mg GAE /g)

132.49±0.56 2.5±0.58 16.15 ±0.59

 

Chromatographic screening for detection of total phenolic, flavonoids and vitamin C levels

HPLC chromatogram revealed the presence of syringic acid as the major phenols followed by salicylic, cinnamic, p-coumaric, gallic, ferulic, caffeic, and chlorogenic acid (Table 3, Figure 6A). Quantification of total flavonoids compounds revealed the presence of rosmarinic acid at the greatest value, followed by catechins, quercetin, rutin, quercitrin, kaempferol, hesperetin, and apigenin (Table 3, Figure 6B). Vitamin C level is shown in (Table 3, Figure 6C).

 

Figure 5: Photomicrographs of heart and aorta sections of rats.

Control group: (A) heart revealed regularly arranged cardiac myofibers with single, ovoid and centrally located nuclei myocytes. (B, C) aorta viewing normal intimal (open arrow), medial (star) and adventitial structures (closed arrow) of aorta. AD- group: heartsection in (D) showing sever myocardial degenerative changes with disarrayed of cardiac myofibers. Additionally, hyaline degeneration (white thin arrows), interstitial edema alongside cardiac hypertrophy (white thick arrows), sever congestion, and dilatation of blood vessels (black arrows). AD- group: aorta section showing: (E) Intimal-vacuolation of the endothelial cells (arrows).(F) Atheromatous plaques under the endothelium (arrow) and formed from fat vacuoles, round cells and macrophages.(G) Subendocardial deposition of fat vacuoles (arrows).(H) Focal endothelial destruction of the endocardium (closed arrow) with subendothelial deposition of fat vacuole (open arrow) with early thrombus formation (star). AD+EEFS group heart section in (I) displaying tissue restoration with mild hyaline degeneration, interstitial edema and congested blood vessels are detected. AD+EEFS group aorta section revealing: (J) normal tunica intima (open arrow), tunica media (star) and tunica adventitia (curved arrow). (K) show degenerative changes mostly fatty change beside necrotic changes in the endothelial and subendothelial layers with apparently normal tunica media (star).

Table 3: Chromatographic screening of total flavonoids, phenolic, and vitamin C levels (μg/ml) of EEGS.

 

 

Chloro-

genic acid

Caffeic acid Ferulic acid Gallic acid P-Coumaric acid Cinnamic acid Salicylic acid Syringic acid Total Phenolic
6.96 8.41 11.38 12.54 14.57 19.14 20.61 21.52
Apigenin Hesperetin Kaempferol Quercitrin Rutin Quercetin Catechins Rosmarinic acid Total Flavonoid
0.67 1.38 1.53 1.58 1.7 1.91 2.09 2.3
0.214 Vitamin C

 

 

Figure 6: HPLC chromatogram of phenolic, flavonoids compounds and vitamin C of EEFS.

(A): Data performs total phenolic compound (A-gallic acid, B-caffeic acid, C chlorogenic acid, D-cinnamic acid, E- ferulic acid, F- p- coumaric acid, G- Salicylic acid, H- Syringic acid); (B): Data performs total flavonoids compound (A-Catechins, B- Quercitrin, C-rutin, D-rosmarinic, E- kaempferol, F-hesperetin, G-apigenin, H-quercetin); (C): Data performs vitamin C content.

 

Discussion

 

The study confirmed AD- induced hyperlipidemia by an increase in TAG, LDL-C, VLDL-C, and TC, and a decrease in HDL-C content. This agrees with previous observations (Jiang et al., 2018; Feng et al., 2019). Naik et al. (2018) reported a relationship between hypercholesterolemia to elevated cholesterol uptake, an overexpression of HMGCR, and increased free fatty acids esterification. A minimized HDL-C level may contribute regression in the LCAT activity that favors cholesterol uptake from tissues to hepatic HDL (Kunnen and Van Eck, 2012).

 

Hyperlipidemia-induced atherosclerosis elevated CRI-I, CRI-II did progress cardiac damage indicated by the raised activity of LDH and AST. These findings agree with Subramania et al. (2017). Dyslipidemia and impaired cholesterol efflux are pivotal factors for cardiovascular disease.Furthermore, an accumulation of macrophage and cholesterol contents results in mitochondrial dysfunction and cell apoptosis (Yao and Tabas, 2001; Han et al., 2018). In the current work, AD-induced inflammatory burden was evident by rise in the levels of pro-inflammatory IL-6, hs CRP, and a decrease in IL-10. This corroborates with the finding reported previously (Siasos et al., 2011; Kondo et al., 2018; Fernández-Gayol et al., 2019). Following atherogenic diet feeding, hs-CRP raised significantly, which is known to controls the inflammatory process of atherogenesis (Kleemann and Kooistra, 2005). These findings mean that AD-induced hyperlipidemia is accompanied by an inflammatory response and cardiac damage. Histopathologically, this can be evident by hyaline degeneration, interstitial edema, cardiac hypertrophy, and the presence of atheromatous plaques under the endothelium of aorta.

 

EEFS reversed AD-induced hyperlipidemia that may be due to their flavonoid and phenols content (Wang et al., 2016; Subramania et al., 2017). A study revealed that quercetin flavonoids minimize the expression of sterol regulatory element-binding protein-1c and fatty acid synthase in the NAFLD model (Li et al., 2013). A meta-analysis indicated that daily administration of 500 mg/day of vitamin C improved endothelial function in diabetic, atherosclerosis, and cardiac failure patient (Ashor et al., 2014). Indeed, due to its SDG, α- ALA, several studies ascertained the hypolipidemic prospect of flaxseed (Edel et al., 2015; Torkan et al., 2015). An ALA-rich diet reduces hepatic lipid deposition by stimulating β-oxidation and by inhibiting fatty acid synthesis (Murase et al., 2005). A study reported hydroxyl radical scavenging impact of SDG of flaxseed in vitro (Prasad, 2000). Another meta-analysis study elucidated that omega-3 treatment minimizes hs-CRP, IL-6, and TNF-α in a different population (Li et al., 2014). Itoh et al. (2010) suggested the antioxidant prospect of vanillic acid in cultured hepatic cells. An administration of quercetin (50 mg/kg) for eight weeks minimized the hepatic inflammation and fibrosis in CCl4-treated mice via depressing macrophages infiltration and downregulated expression of IL-1β, IL-6, and TNFα (Li et al., 2018). The study of Ham et al. (2016) elucidated that administration of 0.05% syringic acid for four months downregulated IL6, TNF-α, NF-κB in obese mice. Syringic acid suppressed the expression of VEGF protein and mRNA in zebrafish embryos (Karthi et al., 2014).The research of Rahbardar et al. (2018) revealed that rosmarinic acid displayed anti-inflammatory prospects in the neuropathic pain model in rats. Hence, EEFS induced hypolipidemic, immunomodulatory, and antioxidant properties via DPPH scavenging in vitro, and in vivo through the upregulation of IL-10.

 

AD-feeding for 12 weeks overexpressed VEGF in a pattern revealed previously (Forstermann and Sessa., 2012; Castiglione et al., 2018). VEGF played a crucial role in angiogenesis. The neovascularization within atherosclerotic plaques is accompanied by thrombotic cascades (Coulon et al., 2012; Camaré et al., 2017). Contrary to this, VEGF expression is suppressed by EEFS treatment in AD-treated rats. This corresponds to the observation of Surapaneni et al. (2015) who described the role of quercetin in minimizing VEGF expression in AD-fed rats. Fan et al. (2017) concluded the anti-inflammatory role of catechins in bowel disease. Francis et al. (2013) concluded that α-ALA control expression of oxidative and inflammatory mediators in vascular tissue minimizing atherosclerosis progression. The histopathological findings confirmed the anti-atherosclerotic and cardioprotective prospect of EEFS, where cardiac tissue restoration with mild hyaline degeneration, interstitial edema with normal tunica intima, tunica media, and tunica adventitia of aorta was observed. This indicates the anti-angiogenic activity of EEFS that may reverse AD-induced atherosclerosis cardiac damage.

 

Conclusion

 

Our research demonstrates the safe administration of EEFS, and its potential impact as a hypolipidemic, immunomodulatory, antiangiogenic, antiatherogenic, and cardioprotective herbal drug. These impacts are largely attributed to its phenolic, flavonoid, and vitamin C content, as well as antioxidant capacity.

 

Authors Contribution

 

All authors contributed equally.

 

Conflicts of interests

The authors declare no conflicts of interest.

 

References

 

  • Ashor AW, Lara J, Mathers JC, Siervo M (2014). Effect of vitamin C on endothelial function in health and disease: a systematic review and meta-analysis of randomised controlled trials. Atherosclerosis. 235: 9–20. https://doi.org/10.1016/j.atherosclerosis.2014.04.004
  • Bahr IH, Abdelghany AA, Galhom A R, Barakat MB, Arafa AE, Fawzy SM (2019). Duloxetine protects against experimental diabetic retinopathy in mice through retinal GFAP downregulation and modulation of neurotrophic factors. Exp. Eye Res. 186: 107742. https://doi.org/10.1016/j.exer.2019.107742
  • Brites F, Martin M, Guillas I, Kontush A (2017). Antioxidative activity of high-density lipoprotein (HDL): Mechanistic insights into potential clinical benefit. BBA Clin. 8: 66–77. https://doi.org/10.1016/j.bbacli.2017.07.002
  • Camaré C, Pucelle M, Nègre-Salvayre A, Salvayre R (2017). Angiogenesis in the atherosclerotic plaque. Redox Biol. 12: 18-34. https://doi.org/10.1016/j.redox.2017.01.007
  • Castiglione RC, Barbosa CML, Prota LFM, Marques-Neto SR, Perri-Oliveira M, Helal-Neto E, Morandi V, Barja-Fidalgo C, Bouskela E (2018). Effects of preadipocytes derived from mice fed with high fat diet on the angiogenic potential of endothelial cells. Nutr. Metab. Cardiovasc. Dis. 28: 937- 943 https://doi.org/10.1016/j.numecd.2018.05.005
  • Coulon S, Francque S, Colle I, Verrijken A, Blomme B, Heindryckx F, Van Vlierberghe H (2012). Evaluation of inflammatory and angiogenic factors in patients with non-alcoholic fatty liver disease. Cytokine. 59: 442-449. https://doi.org/10.1016/j.cyto.2012.05.001
  • Croci AN, Cioroiu B, Lazar D, Corciova A, Ivanescu B, Lazar MI (2009). HPLC evaluation of phenolic and polyphenolic acids from propolis. Farmacia. 57: 52-57. https://doi.org/10.1016/j.amjcard.2009.09.020
  • Dandge PB, Kasabe PJ and Patil RM (2011). Evaluation of medicinal and nutritional components from the Eleagnus conferta fruit. Sci. Res. Rep. 1: 56-60.
  • Davidson MH, Rosenson RS (2009). Novel targets that affect high-density lipoprotein metabolism: The next frontier. Am. J. Cardiol. 104: 52-57.
  • Edel AL, Rodriguez-Leyva D, Maddaford TG, Caligiuri SP, Austria JA, Weighell W, Guzman R, Aliani M, Pierce GN (2015). Dietary flaxseed independently lowers circulating cholesterol and lowers it beyond the effects of cholesterol-lowering medications alone in patients with peripheral artery disease. J. Nutr. 145: 749-757. https://doi.org/10.3945/jn.114.204594
  • Fan F, Sang L, Jiang M (2017). Catechins and their therapeutic benefits to inflammatory bowel disease. Molecules. 22: 484. https://doi.org/10.3390/molecules22030484
  • Feng KZhu XChen TPeng BLu MZheng HHuang QHo CTChen YCao Y (2019). Prevention of Obesity and Hyperlipidemia by Heptamethoxyflavone in High-fat Diet-induced Rats. J. Agric. Food Chem. 67: 2476-2489. https://doi.org/10.1021/acs.jafc.8b05632
  • Fernández-Gayol O, Sanchis P, Aguilar K, Navarro-Sempere A, Comes G, Molinero A, Giralt M, Hidalgo J (2019). Different Responses to a high-fat diet in IL-6 conditional knockout mice driven by constitutive GFAP-Cre and Synapsin -Cre Expression. Neuroendocrinol. 109: 113-130. https://doi.org/10.1159/000496845
  • Forstermann U, Sessa WC (2012). Nitric oxide synthases: regulation and function. Eur. Heart J. 33: 829e37. https://doi.org/10.1093/eurheartj/ehr304
  • Francis AA, Deniset JF, Austria JA, LaValleé RK, Maddaford GG, Hedley TE, Pierce GN (2013). Effects of dietary flaxseed on atherosclerotic plaque regression. Am. J. Physiol. Heart Circ. Physiol. 304: 1743-1751. https://doi.org/10.1152/ajpheart.00606.2012
  • Ghule EA, Jadhav SS, Bodhankar LS (2012). Effect of ethanolic extract of seeds of Linum usitatissimum (Linn.) in hyperglycaemia associated ROS production in PBMNCs and pancreatic tissue of alloxan induced diabetic rats. Asian Pac. J. Trop. Dis. 2012: 405-410. https://doi.org/10.1016/S2222-1808(12)60088-7
  • Hall C, Tulbek MC, Xu Y (2006). Flaxseed. Adv Food Nutr Res. 51:1–97.
  • Haliga RE, Mocanu V, Badescu M (2015). Antioxidative and antiatherogenic effects of flaxseed, α-tocopherol and their combination in diabetic hamsters fed with a high-fat diet. Exp. Ther. Med. 9: 533-538. https://doi.org/10.3892/etm.2014.2102
  • Ham JR, Lee HI, Choi RY, Sim MO, Seo KI, Lee MK (2016). Anti-steatotic and anti-inflammatory roles of syringic acid in high-fat diet-induced obese mice. Food Funct. 7: 689-697. https://doi.org/10.1039/C5FO01329A
  • Han H, Yan P, Chen L, Luo C, Gao H, Deng Q, Zheng M, Shi Yong, Liu L (2015). Flaxseed Oil Containing α-Linolenic Acid Ester of Plant Sterol Improved Atherosclerosis in ApoE Deficient Mice. Oxid. Med. Cell. Longev. Volume 2015, Article ID 958217, 17 pages. https://doi.org/10.1155/2015/958217
  • Han Q, Yeung SC, Ip MSM, Mak JCW (2018). Dysregulation of cardiac lipid parameters in high-fat high-cholesterol diet-induced rat model. Lipids Health Dis. 17: 255. https://doi.org/10.1186/s12944-018-0905-3
  • Hopkins PN (2013). Molecular biology of atherosclerosis. Physiol. Rev. 3: 37–54. https://doi.org/10.1152/physrev.00004.2012
  • Itoh A, Isoda K, Kondoh M, Kawase M, Watari A, Kobayashi M, Tamesada M, Yagi K (2010). Hepatoprotective effect of syringic acid and vanillic acid on CCl4-induced liver injury. Biol. Pharm. Bull., 33: 983-987. https://doi.org/10.1248/bpb.33.983
  • Jiang Y, Fu C, Liu G, Guo J, Su Z (2018). Cholesterol-lowering effects and potential mechanisms of chitooligosaccharide capsules in hyperlipidemic rats. Food Nutr. Res., 62: 1446. https://doi.org/10.29219/fnr.v62.1446
  • Karam I, Yang YJ, Li JY (2017). Hyperlipidemia background and progress SM Atheroscler. J. 1: 1003.
  • Karthi G, Angappanb M, Vijaya A, Natarajapillai S (2014). Syringic acid exerts antiangiogenic activity by downregulation of VEGF in zebrafish embryos. Biomed. Prev. Nutr. 4: 203-208. https://doi.org/10.1016/j.bionut.2014.01.007
  • Kleemann R, Kooistra T (2005). HMG-CoA reductase inhibitors: effects on chronic subacute inflammation and onset of atherosclerosis induced by dietary cholesterol. Curr. Drug Targets Cardiovasc. Hematol. Disord. 2005: 441–453. https://doi.org/10.2174/156800605774962077
  • Kondo H, Abe I, Gotoh K, Fukui A, Takanari H, Ishii Y, Ikebe Y, Kira S, Oniki T, Saito S, Aoki K, Tanino T, Mitarai K, Kawano K, Miyoshi M, Fujinami M, Yoshimura S, Ayabe R, Okada N, Nagano Y, Akioka H, Shinohara T, Akiyoshi K, Masaki T, Teshima Y, Yufu K, Nakagawa M, Takahashi N (2018). Interleukin 10 Treatment Ameliorates High-Fat Diet-Induced Inflammatory Atrial Remodeling and Fibrillation. Circ. Arrhythm. Electrophysiol. 11: e006040. https://doi.org/10.1161/CIRCEP.117.006040
  • Kumar V, Roy BK (2018). Population authentication of the traditional medicinal plant Cassia tora L. based on ISSR markers and FTIR analysis. Sci. Rep. 8: 10714. https://doi.org/10.1038/s41598-018-29114-1
  • Kunnen S, Van Eck M (2012). Lecithin: cholesterol acyltransferase: old friend or foe in atherosclerosis? J. Lipid. Res., 53: 1783-1799. https://doi.org/10.1194/jlr.R024513
  • Li K, Huang T, Zheng J, Wu K, Li D (2014). Effect of marine-derived n-3 polyunsaturated fatty acids on C-reactive protein, interleukin 6 and tumor necrosis factor a meta-analysis. PLoS One, 9: e88103. https://doi.org/10.1371/journal.pone.0088103
  • Li X, Jin Q,Yao Q, Xu B, Li L, Zhang S, Tu C (2018). The Flavonoid Quercetin Ameliorates Liver Inflammation and Fibrosis by Regulating Hepatic Macrophages Activation and Polarization in Mice. Front. Pharmacol. 9: 72. https://doi.org/10.3389/fphar.2018.00072
  • Li X, Wang R, Zhou N, Wang X, Liu Q, Bai Y, Bai Y, Liu Z, Yang H, Zou J, Wang H, Shi T (2013). Quercetin improves insulin resistance and hepatic lipid accumulation in vitro in a NAFLD cell model. Biomed. Rep. 1: 71-76. https://doi.org/10.3892/br.2012.27
  • Machado MV, Diehl AM (2016). Pathogenesis of nonalcoholic steatohepatitis. Gastroenterology, 150: 1769-1777. https://doi.org/10.1053/j.gastro.2016.02.066
  • Morral N, Edenberg HJ, Witting SR, Altomonte J, Chu T, Brown M (2007). Effects of glucose metabolism on the regulation of genes of fatty acid synthesis and triglyceride secretion in the liver. J. Lipid Res. 48: 1499-1510.
  • Murase T, Aoki M, Tokimitsu I (2005). Supplementation with α-linolenic acid-rich diacylglycerol suppresses fatty liver formation accompanied by an up-regulation of β-oxidation in Zucker fatty rats. Biochim. Biophys. Acta, 1733: 224-231 https://doi.org/10.1016/j.bbalip.2004.12.015
  • Naik HS, Srilatha C, Sujatha K, Sreedevi B, Prasad TN (2018). Supplementation of whole grain flaxseeds (Linum usitatissimum) along with high cholesterol diet and its effect on hyperlipidemia and initiated atherosclerosis in Wistar albino male rats. Vet. World, 11: 1433. https://doi.org/10.14202/vetworld.2018.1433-1439
  • Norshazila SJ, Syed ZI, Mustapha SK, Aisyah MR, Kamarul RK (2010). Antioxidant levels and activities of selected seeds of malaysian tropical fruits Malays. J. Nutr. 16:149-59.
  • Olamoyegun MA, Oluyombo R, Asaolu SO (2016). Evaluation of dyslipidemia, lipid ratios, and atherogenic index as cardiovascular risk factors among semi-urban dwellers in Nigeria. Ann. Afr. Med. 15: 194-199. https://doi.org/10.4103/1596-3519.194280
  • Peng J, Lai ZG, Fang ZL, Xing S, Hui K, Hao C, Jin Q, Qi Z, Shen WJ, Dong QN, Bing ZH, Fu DL (2014). Dimethyloxalylglycine Prevents Bone Loss in Ovariectomized C57BL/6J Mice through Enhanced Angiogenesis and Osteogenesis. PLoS One. 9(11): 112744.
  • Prasad K (2000). Antioxidant activity of secoisolariciresinol diglucoside-derived metabolites, secoisolariciresinol, enterodiol, and enterolactone. Int. J. Angiol. 9: 220-225. https://doi.org/10.1007/BF01623898
  • Rahaman MA, Vel D, Janardhan B, Pragathi KN, Deep R (2013). Evaluation of the antihyperlipidemic and anti-atherosclerotic activities of ethanolic extract of Cissus pallida in atherogenic diet fed rat. Int. J. Pharm. Res. Sch. 2: 1–3.
  • Rahbardar MG, Amin B, Mehri S., Mirnajafi-Zadeh SJ, Hosseinzadeh H (2018). Rosmarinic acid attenuates development and existing pain in a rat model of neuropathic pain: An evidence of anti-oxidative and anti-inflammatory effects. Phytomedicine, 40: 59–67. https://doi.org/10.1016/j.phymed.2018.01.001
  • Samson ES, Olasunkanmi AK, Joel JS, Alfred EF (2012). Hematological and hepatotoxic potential of onion (Allium cepa) and garlic (Allium sativum) extracts in rats. Eur. J. Med. Plants. 2: 290. https://doi.org/10.9734/EJMP/2012/1517
  • Siasos G, Tousoulis D, Oikonomou E, Zaromitidou M, Stefanadis CG, Papavassiliou A (2011). Inflammatory markers in hyperlipidemia: from experimental models to clinical practice. Curr. Pharm. Design. 17: 4132-4146. https://doi.org/10.2174/138161211798764780
  • Srinivasan K, Viswanad B, Asrat L, Kaul C L, Ramarao P (2005). Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: a model for type 2 diabetes and pharmacological screening. Pharmacol. Res. 52: 313-320. https://doi.org/10.1016/j.phrs.2005.05.004
  • Subramani C, Rajakkannu A, Rathinam A, Gaidhani S, Raju I, Singh DVK (2017). Anti-atherosclerotic activity of root bark of Premna integrifolia Linn in high fat diet induced atherosclerosis model rats. J. Pharm. Anal. 7: 123-128. https://doi.org/10.1016/j.jpha.2016.12.002
  • Surapaneni KM, Vishnu Priya V, Mallika J (2015). Effect of pioglitazone, quercetin, and hydroxy citric acid on vascular endothelial growth factor messenger RNA (VEGF mRNA) expression in experimentally induced nonalcoholic steatohepatitis (NASH). Turk. J. Med. Sci. 45: 542-546. https://doi.org/10.3906/sag-1404-136
  • Torkan M, Hassan EM, Siavash M (2015). Effect of flaxseed on blood lipid level in hyperlipidemic patients. Rev. Rec. Clin. Trials. 10: 61-67. https://doi.org/10.2174/1574887110666150121154334
  • Walaa I, Mohamaden, Rania Hamad, Hoda I, Bahr (2019). Alterations of Pro-Inflammatory Cytokines and Tissue Protein Expressions in Cats with Interstitial Cystitis. Pak. Vet. J. 39: 151-156. https://doi.org/10.29261/pakvetj/2019.026
  • Wang LL, Zhang ZC, Hassan W, Li Y, Liu J, Shang J (2016). Amelioration of free fatty acid-induced fatty liver by quercetin-3-O-beta-D-glucuronide through modulation of peroxisome proliferator-activated receptor-alpha/sterol regulatory element binding protein-1c signaling, Hepatol. Res. 46: 225–238. https://doi.org/10.1111/hepr.12557
  • Wójcik-Cichy K, Koślińska-Berkan E, Piekarska A (2018). The influence of NAFLD on the risk of atherosclerosis and cardiovascular diseases, Clin. Exp. Hepatol. 4: 1–6. https://doi.org/10.5114/ceh.2018.73155
  • Yao PM, Tabas I (2001). Free cholesterol loading of macrophages is associated with widespread mitochondrial dysfunction and activation of the mitochondrial apoptosis pathway. J. Biol. Chem. 276: 42468–42476. https://doi.org/10.1074/jbc.M101419200
  • Zanwar AA, Hegde VM, Bodhankar LS (2011). Cardioprotective activity of flax lignan concentrate extracted from seeds of Linum usitatissimum in isoprenalin induced myocardial necrosis in rats. Interdiscip. Toxicol. 4: 90–97. https://doi.org/10.2478/v10102-011-0016-8
  • Zhao F, Qi Y, Liu J, Wang W, Xie W, Sun J, Liu J, Hao Y, Wang M, Li Y, Zhao D (2017). Low Very low- Density Lipoprotein Cholesterol but High Very low- Density Lipoprotein Receptor mRNA Expression in Peripheral White Blood Cells: An Atherogenic Phenotype for Atherosclerosis in a Community-Based Population. EBio Med. 25: 136–142. https://doi.org/10.1016/j.ebiom.2017.08.019
  •